A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis
Elisabetta Grillo(University of Brescia), Stefania Mitola(University of Brescia)
Cited by 19
Related Papers
Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine
|The Journal of Immunology|2006|225
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist
|Oncotarget|2016|50
The D647N mutation of FGFR1 induces ligand-independent receptor activation
|Biochimica et Biophysica Acta (BBA) - General Subjects|2023|3